Biotech entity
pharma is the sole category represented across all 2 tracked stories. Of the tracked stories, 1 of 2 also mention Artificial Intelligence, the most common co-covered peer. That works out to roughly 1.3 stories per week across an 11-day span.
Last mentioned: 3d ago
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 2 tracked stories. Of the tracked stories, 1 of 2 also mention Artificial Intelligence, the most common co-covered peer. That works out to roughly 1.3 stories per week across an 11-day span. Source depth averages 2 original sources per story, versus 3.7 across the same-window beat baseline. The 7.5 average consequence score is above the beat benchmark of 6.1 in the same window. Xi Jinping appears in 2 tracked Biotech stories published from March 9, 2026 through March 19, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 171 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Xi Jinping. Shared-story counts are live from our verified record — not editorial picks.
Healthy China 2030 Deadline
Target date for achieving major healthcare and biotech self-sufficiency milestones.
Official Launch
President Xi Jinping unveils the 15th FYP at the National People's Congress.
15th FYP Drafting
Central Committee reviews the initial draft of the 2026-2030 strategic plan.
14th FYP Implementation
Focus on 'Dual Circulation' and initial biotech innovation pivot.
President Xi Jinping’s 15th Five-Year Plan (2026-2030) positions biotechnology as a cornerstone of "New Quality Productive Forces," prioritizing domestic innovation and supply chain self-sufficiency. This strategic shift aims to decouple China’s life sciences sector from Western dependencies while accelerating the commercialization of cell and gene therapies.
Traditional Chinese Medicine (TCM) is undergoing a digital transformation, utilizing AI-assisted acupuncture and digital pulse diagnosis to standardize ancient practices. Supported by China's 'Healthy China 2030' initiative and the 15th Five-Year Plan, these technological advancements aim to provide scientific evidence and global scalability for TCM across 196 countries.
Xi Jinping is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
